Covered recipient · General Payments record
MARCUS L SCARBROUGH
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$592.62
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $319.96 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Nevro Corp. | $89.27 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $33.84 | 2 |
| PFIZER INC. | $33.14 | 2 |
| Lundbeck LLC | $32.09 | 1 |
| Novo Nordisk AS | $27.29 | 2 |
| Amgen Inc. | $26.96 | 2 |
| OptiNose US, Inc. | $23.22 | 1 |
| Neurelis, Inc. | $20.02 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19.05 | 1 |
| EISAI INC. | $15.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $13.64 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111699230 | CMS |
| Amgen Inc. | $13.32 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117375399 | CMS |
| Eisai Inc. | $15.08 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110762809 | CMS |
| Lundbeck LLC | $32.09 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145966036 | CMS |
| Neurelis, Inc. | $20.02 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145653599 | CMS |
| Nevro Corp. | $89.27 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130773228 | CMS |
| Novartis Pharmaceuticals Corporation | $15.47 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087303957 | CMS |
| Novartis Pharmaceuticals Corporation | $18.37 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087303979 | CMS |
| Novo Nordisk Inc | $13.14 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097675099 | CMS |
| Novo Nordisk Inc | $14.15 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096897855 | CMS |
| Optinose US, Inc. | $23.22 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142191624 | CMS |
| PFIZER INC. | $15.03 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131542001 | CMS |
| PFIZER INC. | $18.11 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131512776 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19.05 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153482888 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.